Federal grants to Abzyme Therapeutics LLC
Abzyme Therapeutics LLC in Pottstown, Pennsylvania received $2.4 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Vision Research, with $1.7 million. In fiscal 2025 it was awarded $826,067.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$2.4 million
- Awards3
- Awarded in FY 2025$826,067
- Largest award$1.7 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $399,107 |
| FY 2022 | 0 | $0 |
| FY 2023 | 1 | $299,999 |
| FY 2024 | 1 | $831,927 |
| FY 2025 | 1 | $826,067 |
Programs that fund Abzyme Therapeutics LLC
| Program | Awards | Amount |
|---|---|---|
| Vision Research | 1 | $1.7 million |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 1 | $399,107 |
| Allergy and Infectious Diseases Research | 1 | $299,999 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $2.4 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Multi-specific long-acting antibodies for the treatment of retinal neovascular diseases - abstract. Retinal neovascular diseases including neovascular age-related macular degeneration, diabetic macular edema and retinal vein occlusion are the most vision-threatening diseases in the working-age popul | Vision Research | February 29, 2024 | $1.7 million |
| Brain-cell penetrating antibodies for treatment of progressive multiple sclerosis - abstract. Central nervous system (CNS) physical injuries, including bacterial or viral infection, can induce chronic neuroinflammation that is believed to persist for the lifetime of an individual. Among the other in | Extramural Research Programs in the Neurosciences and Neurological Disorders | September 10, 2021 | $399,107 |
| Novel immune-escape uricase for treatment of hyperuricemia - abstract. High serum urate levels (hyperuricemia) and subsequent monosodium urate crystal deposition cause gout, the most common inflammatory arthritis in men and postmenopausal women. Gout affects an estimated 9.2 million adults in the un | Allergy and Infectious Diseases Research | May 22, 2023 | $299,999 |
Questions people ask
How much federal grant money does Abzyme Therapeutics LLC get?
$2.4 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Abzyme Therapeutics LLC the most?
The Department of Health and Human Services, with $2.4 million in 3 awards.
What is Abzyme Therapeutics LLC's largest federal grant?
$1.7 million under Vision Research, with its first action in the period on February 29, 2024. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Abzyme Therapeutics LLC?
Its largest are Vision Research, Extramural Research Programs in the Neurosciences and Neurological Disorders and Allergy and Infectious Diseases Research.
Other grant recipients in Pottstown
- Community Health and Dental Care, Inc.
- Borough of Pottstown
- YWCA Tri-County Area
- The Schuylkill River Greenway Association
- Creative Health Services, Inc
- Pottstown Cluster of Reli
- PA Flax Project Cooperative Inc.
Largest federal grant recipients in Pennsylvania · Federal grants in Pennsylvania